ROBERT L. VAN NOSTRAND - 31 Mar 2022 Form 4 Insider Report for YIELD10 BIOSCIENCE, INC. (YTEN)

Role
Director
Signature
/s/ Megan N. Gates, attorney-in-fact
Issuer symbol
YTEN
Transactions as of
31 Mar 2022
Net transactions value
+$4,531
Form type
4
Filing time
04 Apr 2022, 17:41:35 UTC
Previous filing
01 Feb 2022
Next filing
26 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction YTEN Stock Option (right to buy) Award $4,531 +908 $4.99* 908 31 Mar 2022 Common Stock 908 $5.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These options were issued to the Reporting Person pursuant to the Issuer's Director Compensation Policy in lieu of $4,531 of cash compensation for services rendered to the Issuer as a member of its Board of Directors and/or a committee thereof during the first quarter of 2022.